These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16863635)

  • 1. [Risperidone and cerebrovascular adverse effects in elderly patients with dementia].
    Formiga F; Fort I; Pérez-Castejón JM; Ruiz D; Duaso E; Riu S
    Rev Clin Esp; 2006 Sep; 206(8):411-2; author reply 412-3. PubMed ID: 16863635
    [No Abstract]   [Full Text] [Related]  

  • 2. Acetylcholinesterase inhibitors for vascular dementia and Alzheimer's disease combined with cerebrovascular disease.
    Bowler JV
    Stroke; 2003 Feb; 34(2):584-6. PubMed ID: 12574580
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors.
    Erkinjuntti T; Román G; Gauthier S
    J Neurol Sci; 2004 Nov; 226(1-2):63-6. PubMed ID: 15537522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of vascular dementia treatment with cholinesterase inhibitors.
    Li Y; Meyer JS; Haque MA; Chowdhury MH; Hinh P; Quach M
    Int J Geriatr Psychiatry; 2002 Feb; 17(2):194-6. PubMed ID: 11813286
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of donepezil for vascular dementia: preliminary clinical experience.
    Mendez MF; Younesi FL; Perryman KM
    J Neuropsychiatry Clin Neurosci; 1999; 11(2):268-70. PubMed ID: 10333999
    [No Abstract]   [Full Text] [Related]  

  • 6. 'Awakenings' in demented patients.
    Hori K; Oda T; Tominaga I; Inada T
    Psychiatry Clin Neurosci; 2003 Apr; 57(2):237. PubMed ID: 12667174
    [No Abstract]   [Full Text] [Related]  

  • 7. Donepezil-treated patients with probable vascular dementia demonstrate cognitive benefits.
    Pratt RD; Perdomo CA
    Ann N Y Acad Sci; 2002 Nov; 977():513-22. PubMed ID: 12480794
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial comment--How to treat vascular dementia?
    Bonelli RM
    Stroke; 2003 Oct; 34(10):2331-2. PubMed ID: 14500926
    [No Abstract]   [Full Text] [Related]  

  • 9. Cholinergic-dopaminergic imbalance in Pisa syndrome.
    Villarejo A; Camacho A; García-Ramos R; Moreno T; Penas M; Juntas R; Ruiz J
    Clin Neuropharmacol; 2003; 26(3):119-21. PubMed ID: 12782913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials.
    Kavirajan H; Schneider LS
    Lancet Neurol; 2007 Sep; 6(9):782-92. PubMed ID: 17689146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donepezil in the treatment of vascular dementia.
    Ebell MH
    Am Fam Physician; 2004 Nov; 70(9):1681-2. PubMed ID: 15554484
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of Cholinesterase Inhibitors in Vascular Dementia: An Updated Meta-Analysis.
    Chen YD; Zhang J; Wang Y; Yuan JL; Hu WL
    Eur Neurol; 2016; 75(3-4):132-41. PubMed ID: 26918649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donepezil in vascular dementia: a viewpoint by Gustavo C. Román.
    Román GC
    Drugs Aging; 2003; 20(15):1137-8. PubMed ID: 14651437
    [No Abstract]   [Full Text] [Related]  

  • 14. Donepezil in vascular dementia: a viewpoint by David S. Geldmacher.
    Geldmacher DS
    Drugs Aging; 2003; 20(15):1137. PubMed ID: 14651436
    [No Abstract]   [Full Text] [Related]  

  • 15. The long-term efficacy and tolerability of donepezil in patients with vascular dementia.
    Wilkinson D; Róman G; Salloway S; Hecker J; Boundy K; Kumar D; Posner H; Schindler R
    Int J Geriatr Psychiatry; 2010 Mar; 25(3):305-13. PubMed ID: 19623601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donepezil minimally effective for patients with vascular dementia.
    Johnson KD
    J Fam Pract; 2004 Mar; 53(3):181-2. PubMed ID: 15000918
    [No Abstract]   [Full Text] [Related]  

  • 17. Donepezil in schizophrenia--is it helpful? An experimental design case study.
    MacEwan GW; Ehmann TS; Khanbhai I; Wrixon C
    Acta Psychiatr Scand; 2001 Dec; 104(6):469-72. PubMed ID: 11782241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donepezil in vascular dementia: a viewpoint by Sandra E. Black.
    Black SE
    Drugs Aging; 2003; 20(15):1138. PubMed ID: 14651438
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of antidementia agents in vascular dementia: beyond Alzheimer disease.
    Farlow MR
    Mayo Clin Proc; 2006 Oct; 81(10):1350-8. PubMed ID: 17036561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of tardive dyskinesia with donepezil.
    Caroff SN; Campbell EC; Havey JC; Sullivan KA; Katz IR; Mann SC
    J Clin Psychiatry; 2001 Feb; 62(2):128-9. PubMed ID: 11247101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.